Form 8-K - Current report:
SEC Accession No. 0001493152-24-020275
Filing Date
2024-05-16
Accepted
2024-05-16 16:52:08
Documents
14
Period of Report
2024-05-10
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47642
  Complete submission text file 0001493152-24-020275.txt   269535

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE tvgn-20240510.xsd EX-101.SCH 3815
3 XBRL DEFINITION FILE tvgn-20240510_def.xml EX-101.DEF 26691
4 XBRL LABEL FILE tvgn-20240510_lab.xml EX-101.LAB 36844
5 XBRL PRESENTATION FILE tvgn-20240510_pre.xml EX-101.PRE 25315
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5977
Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Filer) CIK: 0001860871 (see all company filings)

EIN.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41002 | Film No.: 24956399
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)